EA5231: A Randomized Phase III Trial of Checkpoint blockade in Lung cancer patients in the Adjuvant setting based on pathologic Response following neoadjuvant therapy

Title
A Randomized Phase III Trial of Checkpoint blockade in Lung cancer patients in the Adjuvant setting based on pathologic Response following neoadjuvant therapy
Principal Investigator
Bhasin, Pooja Gogia
Phase
III
Age Group
Adult
Applicable Disease Sites
Lung Cancer
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
Contacts
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Email:
Rachel Harper
Clinical Research Specialist
Phone: +1 304-293-6066
Email:

View on ClinicalTrials.gov